Weibo Dai

441 citations
37 papers · 303 · h-index 11

Impact in

Papers in

    • Natural product bioactivities and synthesis 7
    • Gut microbiota and health 4
    • Pharmacological Effects of Natural Compounds 9
    • Drug-Induced Hepatotoxicity and Protection 3

Weibo Dai

32 papers receiving 301 citations

Peers

Weibo Dai
Comparison fields: 5 of 75
  • Biological Psychiatry 20
  • Pharmacology 40
  • Neurology 35
  • Biochemistry 15
  • Complementary and alternative medicine 20
Replace Nazanin Momeni Roudsari with:
Nazanin Momeni Roudsari Iran
Chaofeng Hu China
Naser‐Aldin Lashgari Iran
Wan Zheng China
Hossein Bagheri Iran
Chi Hern Lee South Korea
Zhe Yu China
Stephanie Badaro‐Garcia Brazil
Shuguang Yan China
Weibo Dai relative to Nazanin Momeni Roudsari Iran Nazanin Momeni Roudsari's profile →
Citations per field
00.5×1.5×
Nazanin Momeni Roudsari · 1×
Citations per year

Countries citing papers authored by Weibo Dai

Since Specialization
Citations

This map shows the geographic impact of Weibo Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Dai more than expected).

Fields of papers citing papers by Weibo Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Dai. The network helps show where Weibo Dai may publish in the future.

Co-authors

The 25 scholars most cited alongside Weibo Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weibo Dai Line = papers co-authored together Weibo Dai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202244
2 202226
3 201724
4 202121
5 202020
6 202320
7 202119
8
Euscaphic acid inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
201918
9 201618
10 202212
11 202310
12 20229
13 20169
14 20228
15 20228
16 20236
17 20215
18 20235
19 20103
20 20243

About Weibo Dai

Weibo Dai is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Complementary and alternative medicine and Biological Psychiatry, having authored 37 papers that have together received 303 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (9 papers), Natural product bioactivities and synthesis (7 papers), Tryptophan and brain disorders (4 papers), Gut microbiota and health (4 papers), Inflammatory Bowel Disease (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Biological Psychiatry (20 citations), Pharmacology (40 citations), Neurology (35 citations), Biochemistry (15 citations) and Complementary and alternative medicine (20 citations). Weibo Dai has collaborated with scholars based in China, Hong Kong and Macao. Frequent co-authors include Xianjing Hu, Xin Liu, Tingting Zhao, Yan Zheng, Lihua Peng, Yuting Guo, Hua Zhou, Peng Sun, Dan Su and Weiwen Peng. Their work appears in journals such as Frontiers in Pharmacology, Scientific Reports, Alexandria Engineering Journal, Molecules and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact